Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
zoledronic acid farnesyl pyrophosphate synthase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Neoplasm Metastasis[MeSHID:D009362]
Osteitis Deformans[MeSHID:D010001]
Bone neoplasms[MeSHID:D001859]
Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390]
Postmenopause[MeSHID:D017698]
Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]		 4.55 approved inhibitor
zoledronic acid farnesyl pyrophosphate synthase small molecule NA drugbank , DGIDB Multiple Myeloma[MeSHID:D009101]
Neoplasm Metastasis[MeSHID:D009362]
Osteitis Deformans[MeSHID:D010001]
Bone neoplasms[MeSHID:D001859]
Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390]
Postmenopause[MeSHID:D017698]
Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]		 NA approved inhibitor
zoledronic acid geranylgeranyl pyrophosphate synthase small molecule NA drugbank Multiple Myeloma[MeSHID:D009101]
Neoplasm Metastasis[MeSHID:D009362]
Osteitis Deformans[MeSHID:D010001]
Bone neoplasms[MeSHID:D001859]
Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390]
Postmenopause[MeSHID:D017698]
Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]		 NA approved inhibitor
zoledronic acid hydroxylapatite small molecule NA drugbank Multiple Myeloma[MeSHID:D009101]
Neoplasm Metastasis[MeSHID:D009362]
Osteitis Deformans[MeSHID:D010001]
Bone neoplasms[MeSHID:D001859]
Humoral hypercalcemia of malignancy (disorder)[MeSHID:C562390]
Postmenopause[MeSHID:D017698]
Bone Tissue[MeSHID:D001842]
Osteoporosis[MeSHID:D010024]		 NA approved antagonist,binder
click here to return to the previous page